Recruiting Pulmonary Fibrosis Studies in Stanford
About Pulmonary Fibrosis Clinical Trials in Stanford
Pulmonary fibrosis is a condition in which the lung tissue becomes damaged and scarred, making it difficult for the lungs to function properly. Idiopathic pulmonary fibrosis (IPF) is the most common form with unknown cause. Antifibrotic medications can slow progression, and lung transplant may be considered.
There are currently 1 pulmonary fibrosis clinical trials recruiting participants in Stanford, CA. These studies are seeking a combined 698 participants. Research is being sponsored by United Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Fibrosis Clinical Trials in Stanford — FAQ
Are there pulmonary fibrosis clinical trials in Stanford?
Yes, there are 1 pulmonary fibrosis clinical trials currently recruiting in Stanford, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Stanford?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.
Are clinical trials in Stanford free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.
What pulmonary fibrosis treatments are being tested?
The 1 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary fibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov